|
Purpose This study aimed to verify the safety of low-dose topiramate on language development in pediatric patients with migraine. MethodsThirty newly diagnosed pediatric patients with migraine who needed topiramate were enrolled and assessed twice with standard language tests, including the Test of Language Problem Solving Abilities (TOPs), Receptive and Expressive Vocabulary Test, Urimal Test of Articulation and Phonology, and computerized speech laboratory... |
